Long way to go....11 Jan 2017 13:52
Biotechs are notorious for being risky and " very long term holds." Personally I don't see anything startling on the horizon for years. Been here for years and the last spike to 13p was caused by re-financing courtesy of Vulpes . Trials are still years away . Hoping that the manufacturing side may lift the sp a little but very quiet on that front.
Selling is always difficult, but often the best decision.